S A Waldman Selected Research

Enterotoxin Receptors

9/2008	Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy.
12/2007	Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
10/2007	The paracrine hormone hypothesis of colorectal cancer.
3/2003	Bacterial enterotoxins are associated with resistance to colon cancer.
10/2001	Nucleotide requirements for CDX2 binding to the cis promoter element mediating intestine-specific expression of guanylyl cyclase C.
10/2001	Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.
7/2001	Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.
2/2000	A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S A Waldman Research Topics

Disease

11	Colorectal Neoplasms (Colorectal Cancer) 11/2009 - 02/2000
6	Neoplasms (Cancer) 11/2009 - 03/2003
3	Obesity 05/2016 - 06/2010
3	Colonic Neoplasms (Colon Cancer) 11/2009 - 07/2000
2	Carcinogenesis 11/2009 - 09/2008
2	Carcinoma (Carcinomatosis) 10/2001 - 07/2001
1	Glucose Intolerance 05/2016
1	Chronic Disease (Chronic Diseases) 01/2014
1	Weight Loss (Weight Reduction) 01/2014
1	Dementia (Dementias) 01/2014
1	Infections 01/2014
1	Metabolic Diseases (Metabolic Disease) 06/2010
1	Diarrhea 10/2001
1	Circulating Neoplastic Cells 10/2001
1	Necrosis 07/2001
1	Rectal Neoplasms (Rectal Cancer) 07/2000
1	Renal Insufficiency (Renal Failure) 07/2000
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2000

Drug/Important Bio-Agent (IBA)

8	Enterotoxin ReceptorsIBA 09/2008 - 02/2000
5	LigandsIBA 11/2009 - 07/2001
4	Hormones (Hormone)IBA 05/2016 - 10/2007
4	uroguanylinIBA 05/2016 - 07/2001
3	Enterotoxins (Enterotoxin)IBA 09/2008 - 10/2001
2	guanylinIBA 11/2009 - 09/2008
2	AzoxymethaneIBA 11/2009 - 09/2008
2	CarcinogensIBA 11/2009 - 09/2008
2	DNA (Deoxyribonucleic Acid)IBA 03/2003 - 07/2001
1	CarbohydratesIBA 05/2016
1	Tamoxifen FDA LinkGeneric 05/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Pharmaceutical PreparationsIBA 06/2010
1	Proteins (Proteins, Gene)FDA Link 12/2007
1	AntigensIBA 12/2007
1	Chelating AgentsIBA 01/2005
1	Peptides (Polypeptides)IBA 01/2005
1	IonsIBA 01/2005
1	Peptide Nucleic AcidsIBA 01/2005
1	MetalsIBA 01/2005
1	Diltiazem (Cardizem)FDA LinkGeneric 03/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2001
1	RNA (Ribonucleic Acid)IBA 10/2001
1	Messenger RNA (mRNA)IBA 10/2001
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 07/2001
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2001
1	Guanylyl Cyclase C AgonistsIBA 07/2001
1	Biotin (Vitamin H)FDA Link 07/2001
1	heat stable toxin (E coli)IBA 07/2001
1	Trypan Blue FDA Link 07/2001
1	4- (7- ((2- 3- chloro- 2- thienyl)- 1- methyl- propylamino)- 3H- imidazo(4,5- b)pyridyl- 3- yl)cyclopentane carboxamideIBA 07/2000
1	Adenosine (Adenocard)FDA LinkGeneric 07/2000
1	Complement System Proteins (Complement)IBA 02/2000
1	Biomarkers (Surrogate Marker)IBA 02/2000

Therapy/Procedure

6	Therapeutics 01/2014 - 05/2000
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 11/2009 - 09/2008
1	Drug Therapy (Chemotherapy) 06/2010
1	Immunotherapy 12/2007
1	Intravenous Infusions 07/2000
1	Adjuvant Chemotherapy 05/2000